Inventor · disambiguated record
Gino Villetti
Also filed as: VILLETTI GINO
10 granted patents·15 pending applications·55 citations·filing 1997–2025
87Inventor score
Top patents by PatentIndex Score
25 records- 0194US7968724B2Ester derivatives as phosphodiesterase inhibitorsCHIESI FARMA SPA·Filed 2008·Granted Jun 28, 2011·16 cites·42 claims
- 0287US8022250B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2009·Granted Sep 20, 2011·10 cites·6 claims
- 0379US7662995B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2004·Granted Feb 16, 2010·12 cites·26 claims
- 0472US8314268B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesRAVEGLIA LUCA·Filed 2011·Granted Nov 20, 2012·3 cites·18 claims
- 0571US7838534B2Quinuclidine derivatives as M3 antagonistsCHIESI FARMA SPA·Filed 2007·Granted Nov 23, 2010·2 cites·8 claims
- 0671US7507710B2Anti-amyloid immunogenic compositions, methods and usesCHIESI FARMA SPA·Filed 2007·Granted Mar 24, 2009·2 cites·30 claims
- 0769US7531692B2Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2005·Granted May 12, 2009·1 cites·21 claims
- 0866US2022218678A1Use of 1-phenyl-2-pyridinyl alkyl alcohol derivatives for treating cystic fibrosisCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 0960US9150489B21-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosisIMBIMBO BRUNO PIETRO·Filed 2011·Granted Oct 6, 2015·2 cites·25 claims
- 1060US2021038575A1Use of 1-phenyl-2-pyridinyl alkyl alcohol derivatives for treating cystic fibrosisCHIESI FARM SPA·Filed 2018·Application pending·0 cites
- 1159US2009181935A1Compositions comprising an antimuscarinic and a long-acting beta-agonistCHIESI FARMA SPA·Filed 2008·Application pending·0 cites
- 1258US2024165203A1Combined treatment of brain injuryCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1357US2022064243A1Agent for treatment of dermatological disordersCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 1456US2025277010A1Agent for treatment of dermatological disordersCHIESI FARM SPA·Filed 2025·Application pending·0 cites
- 1554US2014057882A1Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitorsCHIESI FARMA SPA·Filed 2013·Application pending·0 cites
- 1653US2009186033A1Anti-amyloid immunogenic compositions, methods and usesCHIESI FARMA SPA·Filed 2009·Application pending·0 cites
- 1752US2013005716A1Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitorsCHIESI FARMA SPA·Filed 2012·Application pending·0 cites
- 1851US2022401517A1Agent for use in treatment or prevention of ophthalmic disordersCHIESI FARM SPA·Filed 2020·Application pending·0 cites
- 1947US9931327B2Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitorsCHIESI FARM SPA·Filed 2015·Granted Apr 3, 2018·0 cites·19 claims
- 2047US6114391Aα-amino acid amides, preparation thereof and the therapeutical use thereofCHIESI FARMA SPA·Filed 1997·Granted Sep 5, 2000·7 cites·14 claims
- 2146US2010028353A1Anti-amyloid immunogenic compositions, methods and usesCHIESI FARMA SPA·Filed 2009·Application pending·0 cites
- 2244US2008287480A1Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic SubstanceCHIESI FARMA SPA·Filed 2006·Application pending·0 cites
- 2341US2005222266A12-indanylamino derivatives for the therapy of chronic painCHIESI FARMA SPA·Filed 2002·Application pending·0 cites
- 2440US2009005364A1Azole Derivatives With Antimuscarinic ActivityPERETTO ILARIA·Filed 2005·Application pending·0 cites
- 2526US2012022163A11-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the therapy of prion diseasesIMBIMBO BRUNO PIETRO·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gino Villetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →